Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.

Emerging infectious diseases - 1 Jan 2013

Eshaghi AliReza, Memari Nader, Tang Patrick, Olsha Romy, Farrell David J, Low Donald E, Gubbay Jonathan B, Patel Samir N

Abstract excerpt

Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens and isolates obtained during 2011-2012 in Ontario, Canada. Of 91 M. pneumoniae drug-resistant specimens, 11 (12.1%) carried nucleotide mutations associated with macrolide resistance in the 23S rRNA gene. None of the M. pneumoniae specimens were resistant to fluoroquinolones or tetracyclines.

Topics

Join the communities discussing this publication.

Anti-Bacterial Agents
Drug Resistance, Bacterial
Genes, Bacterial
Macrolides
Multilocus Sequence Typing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Mycoplasma pneumoniae

Pneumonia, Mycoplasma

Source

Open in PubMed Open full text

Identifiers

PMID: 23968896
DOI: 10.3201/eid1909.121466
PMCID: PMC3810904

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.PMID 23968896Read ↗

Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018.Semantic proximity Read ↗

<i>Mycoplasma Pneumoniae</i> : Susceptibility and Resistance To AntibioticsSemantic proximity Read ↗

Molecular insights into macrolide resistant Mycoplasma pneumoniae isolates from outpatient clinics in Tehran, Iran.Semantic proximity Read ↗

Antimicrobial susceptibility and genotyping of Mycoplasma pneumoniae isolates in Beijing, China, from 2014 to 2016Semantic proximity Read ↗

Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.Semantic proximity Read ↗

Drug Resistance Mechanisms of<i>Mycoplasma pneumoniae</i>to Macrolide AntibioticsSemantic proximity Read ↗

Antimicrobial susceptibility and molecular characteristics of Mycoplasma pneumoniae isolates across different regions of ChinaSemantic proximity Read ↗

Low Incidence of Macrolide-Resistant Mycoplasma pneumoniae between April 2016 and March 2017 in Akita Prefecture, Japan.Semantic proximity Read ↗

Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK.Semantic proximity Read ↗

First Detection and Characterization of Macrolide-Resistant Mycoplasma pneumoniae from People with Community-Acquired Pneumonia in IranSemantic proximity Read ↗

Molecular detection and evaluation of resistance of Mycoplasma Pneumoniae to macrolide (Erythromycin) due to mutation in the 23S rRNA gene among Iranian Patients with respiratory infectionsSemantic proximity Read ↗

Multilocus Sequence Typing ofMycoplasma pneumoniae, Japan, 2002–2016Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.